1. 1081Immunogenicity of Human Papilloma Vaccine Coadministered with an Investigational Bivalent rLP2086 Vaccine Against Meningococcal Serogroup B in Healthy Adolescents. (December 2014) Authors: Bhuyan, Prakash; Eiden, Joseph; Jones, Thomas R.; York, Laura J.; Ginis, John; Jansen, Kathrin U.; Perez, John L. Journal: Open forum infectious diseases Issue: Volume 1(2014)Supplement 1 Page Start: S317 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase 1 randomized study assessing safety and immunogenicity of two 3-dose regimens of a Clostridium difficile vaccine in healthy older Japanese adults. Issue 19 (1st May 2019) Authors: Inoue, Megumi; Yonemura, Takuma; de Solom, Richard; Yamaji, Masako; Aizawa, Masakazu; Knirsch, Charles; Pride, Michael W.; Jansen, Kathrin U.; Gruber, William; Webber, Chris Journal: Vaccine Issue: Volume 37:Issue 19(2019) Page Start: 2600 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A phase 1, placebo-controlled, randomized study of the safety, tolerability, and immunogenicity of a Clostridium difficile vaccine administered with or without aluminum hydroxide in healthy adults. Issue 18 (19th April 2016) Authors: Sheldon, Eric; Kitchin, Nicholas; Peng, Yahong; Eiden, Joseph; Gruber, William; Johnson, Erik; Jansen, Kathrin U.; Pride, Michael W.; Pedneault, Louise Journal: Vaccine Issue: Volume 34:Issue 18(2016) Page Start: 2082 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A Phase 2, Randomized, Active-controlled, Observer-blinded Study to Assess the Immunogenicity, Tolerability and Safety of Bivalent rLP2086, a Meningococcal Serogroup B Vaccine, Coadministered With Tetanus, Diphtheria and Acellular Pertussis Vaccine and Serogroup A, C, Y and W-135 Meningococcal Conjugate Vaccine in Healthy US Adolescents. Issue 6 (June 2016) Authors: Muse, Derek; Christensen, Shane; Bhuyan, Prakash; Absalon, Judith; Eiden, Joseph J.; Jones, Thomas R.; York, Laura J.; Jansen, Kathrin U.; O'Neill, Robert E.; Harris, Shannon L.; Perez, John L. Journal: Pediatric infectious disease journal Issue: Volume 35:Issue 6(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A phase 3, randomized, active-controlled study to assess the safety and tolerability of meningococcal serogroup B vaccine bivalent rLP2086 in healthy adolescents and young adults. Issue 12 (14th March 2016) Authors: Ostergaard, Lars; Lucksinger, Gregg H.; Absalon, Judith; Beeslaar, Johannes; Eiden, Joseph; Jansen, Kathrin U.; York, Laura J.; Quinn, Angela; Graversen, Mette E.; Perez, John L. Journal: Vaccine Issue: Volume 34:Issue 12(2016) Page Start: 1465 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A phase 3, randomized, double-blind study to evaluate the immunogenicity and safety of 3 lots of 20-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naive adults 18 through 49 years of age. Issue 38 (7th September 2021) Authors: Klein, Nicola P.; Peyrani, Paula; Yacisin, Kari; Caldwell, Nicole; Xu, Xia; Scully, Ingrid L.; Scott, Daniel A.; Jansen, Kathrin U.; Gruber, William C.; Watson, Wendy Journal: Vaccine Issue: Volume 39:Issue 38(2021) Page Start: 5428 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A randomized phase 1 study of the safety and immunogenicity of 2 novel pneumococcal conjugate vaccines in healthy Japanese adults in the United States. Issue 7 (3rd July 2021) Authors: Fitz-Patrick, David; Young Jr, Mariano; Scott, Daniel A.; Scully, Ingrid L.; Baugher, Gary; Peng, Yahong; Jansen, Kathrin U.; Gruber, William; Watson, Wendy Journal: Human vaccines & immunotherapeutics Issue: Volume 17:Issue 7(2021) Page Start: 2249 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. A randomized phase 1/2 study of the safety and immunogenicity of a multivalent pneumococcal conjugate vaccine in healthy adults 50 through 85 years of age. Issue 8 (3rd August 2021) Authors: Essink, Brandon; Peterson, James; Yacisin, Kari; Lal, Himal; Mirza, Sarah; Xu, Xia; Scully, Ingrid L.; Scott, Daniel A.; Gruber, William C.; Jansen, Kathrin U.; Watson, Wendy Journal: Human vaccines & immunotherapeutics Issue: Volume 17:Issue 8(2021) Page Start: 2691 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. A randomized phase I study of the safety and immunogenicity of three ascending dose levels of a 3-antigen Staphylococcus aureus vaccine (SA3Ag) in healthy adults. Issue 15 (8th April 2015) Authors: Nissen, Michael; Marshall, Helen; Richmond, Peter; Shakib, Sepehr; Jiang, Qin; Cooper, David; Rill, Denise; Baber, James; Eiden, Joseph; Gruber, William; Jansen, Kathrin U.; Emini, Emilio A.; Anderson, Annaliesa S.; Zito, Edward T.; Girgenti, Douglas Journal: Vaccine Issue: Volume 33:Issue 15(2015) Page Start: 1846 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. A trial to evaluate the safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine in populations of adults ≥65 years of age with different prior pneumococcal vaccination. Issue 51 (17th December 2021) Authors: Cannon, Kevin; Elder, Charles; Young, Mariano; Scott, Daniel A.; Scully, Ingrid L.; Baugher, Gary; Peng, Yahong; Jansen, Kathrin U.; Gruber, William C.; Watson, Wendy Journal: Vaccine Issue: Volume 39:Issue 51(2021) Page Start: 7494 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗